154 related articles for article (PubMed ID: 4024101)
1. Effects of 3-methylcholanthrene and phenobarbital on the capacity of embryos to bioactivate teratogens during organogenesis.
Juchau MR; Giachelli CM; Fantel AG; Greenaway JC; Shepard TH; Faustman-Watts EM
Toxicol Appl Pharmacol; 1985 Aug; 80(1):137-46. PubMed ID: 4024101
[TBL] [Abstract][Full Text] [Related]
2. Generation of reactive dysmorphogenic intermediates by rat embryos in culture: effects of cytochrome P-450 inducers.
Juchau MR; Bark DH; Shewey LM; Greenaway JC
Toxicol Appl Pharmacol; 1985 Dec; 81(3 Pt 1):533-44. PubMed ID: 4082200
[TBL] [Abstract][Full Text] [Related]
3. Abnormal neurulation induced by 7-hydroxy-2-acetylaminofluorene and acetaminophen: evidence for catechol metabolites as proximate dysmorphogens.
Harris C; Stark KL; Luchtel DL; Juchau MR
Toxicol Appl Pharmacol; 1989 Dec; 101(3):432-46. PubMed ID: 2603160
[TBL] [Abstract][Full Text] [Related]
4. Analysis of metabolites of 2-acetylaminofluorene generated in an embryo culture system. Relationship of biotransformation to teratogenicity in vitro.
Faustman-Watts EM; Namkung MJ; Greenaway JC; Juchau MR
Biochem Pharmacol; 1985 Aug; 34(16):2953-9. PubMed ID: 4026879
[TBL] [Abstract][Full Text] [Related]
5. Teratogenicity in vitro of two deacetylated metabolites of N-hydroxy-2-acetylaminofluorene.
Faustman-Watts EM; Greenaway JC; Namkung MJ; Fantel AG; Juchau MR
Toxicol Appl Pharmacol; 1984 Oct; 76(1):161-71. PubMed ID: 6484986
[TBL] [Abstract][Full Text] [Related]
6. Specific labelling of microsomal proteins by reactive intermediates generated from 2-acetylaminofluorene in vitro.
Kaderbhai MA; Bradshaw TK; Freedman RB
Chem Biol Interact; 1981 Aug; 36(2):211-27. PubMed ID: 7273244
[TBL] [Abstract][Full Text] [Related]
7. Carbon monoxide inhibits monooxygenation by the conceptus and embryotoxic effects of proteratogens in vitro.
Faustman-Watts EM; Giachelli CM; Juchau MR
Toxicol Appl Pharmacol; 1986 May; 83(3):590-5. PubMed ID: 3705078
[TBL] [Abstract][Full Text] [Related]
8. Mutagenic, cytotoxic, and teratogenic effects of 2-acetylaminofluorene and reactive metabolites in vitro.
Faustman-Watts EM; Yang HY; Namkung MJ; Greenaway JC; Fantel AG; Juchau MR
Teratog Carcinog Mutagen; 1984; 4(3):273-83. PubMed ID: 6147026
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of 2-acetylaminofluorene by two 3-methylcholanthrene-inducible forms of rat liver cytochrome P-450.
Goldstein JA; Weaver R; Sundheimer DW
Cancer Res; 1984 Sep; 44(9):3768-71. PubMed ID: 6744296
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the embryotoxicity in vitro of reactive metabolites of 2-acetylaminofluorene by reduced glutathione and ascorbate and via sulfation.
Faustman-Watts EM; Namkung MJ; Juchau MR
Toxicol Appl Pharmacol; 1986 Dec; 86(3):400-10. PubMed ID: 3787633
[TBL] [Abstract][Full Text] [Related]
11. The in vitro teratogenicity of cyclophosphamide in rat embryos.
Greenaway JC; Fantel AG; Shepard TH; Juchau MR
Teratology; 1982 Jun; 25(3):335-43. PubMed ID: 7112435
[TBL] [Abstract][Full Text] [Related]
12. Modulation of cytotoxic and genotoxic effects of 2-acetylaminofluorene in rat and hamster hepatocytes by 3-methylcholanthrene pre-treatment.
Holme JA; Søderlund EJ; Christensen T; Trygg B; Bjørnstad C
Carcinogenesis; 1986 Sep; 7(9):1561-7. PubMed ID: 3742728
[TBL] [Abstract][Full Text] [Related]
13. [Embryotoxic effect of cyclophosphamide after being biotransformed in a culture of postimplantation rat embryos].
Popov VB; Vaĭsman BL; Puchkov VF
Biull Eksp Biol Med; 1981 May; 91(5):613-5. PubMed ID: 7260395
[TBL] [Abstract][Full Text] [Related]
14. Antibody inhibition of oxidative activation and inactivation of the carcinogen 2-acetylaminofluorene by purified hepatic cytochrome P-450 from 3-methylcholanthrene pretreated rats.
Pandey RN; Clearfield MS; Paik SM; Lotlikar PD
Cancer Lett; 1983 Jul; 19(3):263-71. PubMed ID: 6411328
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the embryotoxicity and cytotoxicity elicited by 7-hydroxy-2-acetylaminofluorene and acetaminophen via deacetylation.
Stark KL; Harris C; Juchau MR
Toxicol Appl Pharmacol; 1989 Mar; 97(3):548-60. PubMed ID: 2609350
[TBL] [Abstract][Full Text] [Related]
16. Oxidative activation and inactivation of the carcinogen 2-acetylaminofluorene by various purified cytochromes P-450 from 3-methylcholanthrene pretreated rats.
Lotlikar PD; Pandey RN; Clearfield MS; Paik SM
Toxicol Lett; 1984 Apr; 21(1):111-8. PubMed ID: 6426096
[TBL] [Abstract][Full Text] [Related]
17. The suppressive effect of hepatic 9,000 x G supernatant fraction from 3-methylcholanthrene-treated rats on the mutagenic activity of 2-acetylaminofluorene.
Kojima A; Kawano S; Hiraga K
Jpn J Pharmacol; 1980 Aug; 30(4):421-6. PubMed ID: 7206358
[TBL] [Abstract][Full Text] [Related]
18. Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring- and N-hydroxylations of N-2-fluorenylacetamide.
Malejka-Giganti D; Decker RW; Ritter CL; Polovina MR
Carcinogenesis; 1985 Jan; 6(1):95-103. PubMed ID: 3967341
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of N- and C-hydroxylations of 2-acetylaminofluorene in male Sprague-Dawley rat liver microsomes: implications for carcinogenesis.
McManus ME; Minchin RF; Sanderson N; Wirth PJ; Thorgeirsson SS
Cancer Res; 1983 Aug; 43(8):3720-4. PubMed ID: 6861141
[TBL] [Abstract][Full Text] [Related]
20. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
Hales BF
Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
